Fortress Inventory Turnover from 2010 to 2024
FBIO Stock | USD 1.84 0.01 0.55% |
Inventory Turnover | First Reported 2010-12-31 | Previous Quarter 2.83068783 | Current Value 2.69 | Quarterly Volatility 236.73082947 |
Check Fortress Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fortress main balance sheet or income statement drivers, such as Interest Expense of 6.5 M, Selling General Administrative of 104.7 M or Research Development of 59.7 M, as well as many exotic indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.38 or PTB Ratio of 1.03. Fortress financial statements analysis is a perfect complement when working with Fortress Biotech Valuation or Volatility modules.
Fortress | Inventory Turnover |
Latest Fortress Biotech's Inventory Turnover Growth Pattern
Below is the plot of the Inventory Turnover of Fortress Biotech over the last few years. It is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. Fortress Biotech's Inventory Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fortress Biotech's overall financial position and show how it may be relating to other accounts over time.
Inventory Turnover | 10 Years Trend |
|
Inventory Turnover |
Timeline |
Fortress Inventory Turnover Regression Statistics
Arithmetic Mean | 91.78 | |
Geometric Mean | 21.54 | |
Coefficient Of Variation | 257.93 | |
Mean Deviation | 113.46 | |
Median | 55.91 | |
Standard Deviation | 236.73 | |
Sample Variance | 56,041 | |
Range | 941 | |
R-Value | (0.1) | |
Mean Square Error | 59,782 | |
R-Squared | 0.01 | |
Significance | 0.73 | |
Slope | (5.15) | |
Total Sum of Squares | 784,581 |
Fortress Inventory Turnover History
About Fortress Biotech Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Fortress Biotech income statement, its balance sheet, and the statement of cash flows. Fortress Biotech investors use historical funamental indicators, such as Fortress Biotech's Inventory Turnover, to determine how well the company is positioned to perform in the future. Although Fortress Biotech investors may use each financial statement separately, they are all related. The changes in Fortress Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fortress Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fortress Biotech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fortress Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Inventory Turnover | 2.83 | 2.69 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Fortress Biotech Correlation against competitors. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Fortress Stock analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Fortress Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.74) | Revenue Per Share 7.954 | Quarterly Revenue Growth 0.048 | Return On Assets (0.34) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.